Cargando…

Poor treatment outcomes of children on highly active antiretroviral therapy: protocol for a systematic review and meta-analysis

INTRODUCTION: While access to highly active antiretroviral therapy (HAART) for children with HIV has expanded and the use of HAART has substantially reduced the morbidity and mortality of children due to HIV, poor treatment outcomes among children with HIV are still a major public health problem glo...

Descripción completa

Detalles Bibliográficos
Autores principales: Atalell, Kendalem Asmare, Alene, Kefyalew Addis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778777/
https://www.ncbi.nlm.nih.gov/pubmed/33376164
http://dx.doi.org/10.1136/bmjopen-2020-040161
_version_ 1783631192998805504
author Atalell, Kendalem Asmare
Alene, Kefyalew Addis
author_facet Atalell, Kendalem Asmare
Alene, Kefyalew Addis
author_sort Atalell, Kendalem Asmare
collection PubMed
description INTRODUCTION: While access to highly active antiretroviral therapy (HAART) for children with HIV has expanded and the use of HAART has substantially reduced the morbidity and mortality of children due to HIV, poor treatment outcomes among children with HIV are still a major public health problem globally. The aim of this systematic review and meta-analysis is to quantify treatment outcomes among children with HIV. METHODS AND ANALYSIS: Systematic searches will be conducted in three electronic databases (PubMed, SCOPUS and Web of Science) for recent studies published from 01 Jan 2000 up to 28 October 2020, without geographical restriction. The primary outcomes of the study will be poor treatment outcomes, which include death, treatment failure and loss to follow-up. We will include quantitative studies that report treatment outcomes among children under the age of 18 years with HIV. Studies will be excluded if they are case report, case series, conducted among adults only or do not provide data on treatment outcomes for children. Two researchers will screen the titles and abstracts of all citations identified in our search, then review the full text of the remaining papers to identify those that meet the inclusion criteria. The Newcastle–Ottawa Scale will be used for quality assessment. A random-effects meta-analysis will be used to obtain pooled estimates of the proportion of poor treatment outcomes. The heterogeneity between studies will be checked visually by using forest plots and quantitatively measured by the index of heterogeneity (I(2)). Pooled estimates of poor treatment outcomes will be calculated with a random-effects model. Subgroup analysis will be conducted by study settings, treatment regimen, comorbidity (such as tuberculosis), study period and HIV type (HIV-1 and HIV-2). ETHICS AND DISSEMINATION: Ethical approval will not be required for this study as it will be based on published papers. The final report of this review will be published in a peer-reviewed scientific journal.
format Online
Article
Text
id pubmed-7778777
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-77787772021-01-11 Poor treatment outcomes of children on highly active antiretroviral therapy: protocol for a systematic review and meta-analysis Atalell, Kendalem Asmare Alene, Kefyalew Addis BMJ Open HIV/AIDS INTRODUCTION: While access to highly active antiretroviral therapy (HAART) for children with HIV has expanded and the use of HAART has substantially reduced the morbidity and mortality of children due to HIV, poor treatment outcomes among children with HIV are still a major public health problem globally. The aim of this systematic review and meta-analysis is to quantify treatment outcomes among children with HIV. METHODS AND ANALYSIS: Systematic searches will be conducted in three electronic databases (PubMed, SCOPUS and Web of Science) for recent studies published from 01 Jan 2000 up to 28 October 2020, without geographical restriction. The primary outcomes of the study will be poor treatment outcomes, which include death, treatment failure and loss to follow-up. We will include quantitative studies that report treatment outcomes among children under the age of 18 years with HIV. Studies will be excluded if they are case report, case series, conducted among adults only or do not provide data on treatment outcomes for children. Two researchers will screen the titles and abstracts of all citations identified in our search, then review the full text of the remaining papers to identify those that meet the inclusion criteria. The Newcastle–Ottawa Scale will be used for quality assessment. A random-effects meta-analysis will be used to obtain pooled estimates of the proportion of poor treatment outcomes. The heterogeneity between studies will be checked visually by using forest plots and quantitatively measured by the index of heterogeneity (I(2)). Pooled estimates of poor treatment outcomes will be calculated with a random-effects model. Subgroup analysis will be conducted by study settings, treatment regimen, comorbidity (such as tuberculosis), study period and HIV type (HIV-1 and HIV-2). ETHICS AND DISSEMINATION: Ethical approval will not be required for this study as it will be based on published papers. The final report of this review will be published in a peer-reviewed scientific journal. BMJ Publishing Group 2020-12-29 /pmc/articles/PMC7778777/ /pubmed/33376164 http://dx.doi.org/10.1136/bmjopen-2020-040161 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle HIV/AIDS
Atalell, Kendalem Asmare
Alene, Kefyalew Addis
Poor treatment outcomes of children on highly active antiretroviral therapy: protocol for a systematic review and meta-analysis
title Poor treatment outcomes of children on highly active antiretroviral therapy: protocol for a systematic review and meta-analysis
title_full Poor treatment outcomes of children on highly active antiretroviral therapy: protocol for a systematic review and meta-analysis
title_fullStr Poor treatment outcomes of children on highly active antiretroviral therapy: protocol for a systematic review and meta-analysis
title_full_unstemmed Poor treatment outcomes of children on highly active antiretroviral therapy: protocol for a systematic review and meta-analysis
title_short Poor treatment outcomes of children on highly active antiretroviral therapy: protocol for a systematic review and meta-analysis
title_sort poor treatment outcomes of children on highly active antiretroviral therapy: protocol for a systematic review and meta-analysis
topic HIV/AIDS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778777/
https://www.ncbi.nlm.nih.gov/pubmed/33376164
http://dx.doi.org/10.1136/bmjopen-2020-040161
work_keys_str_mv AT atalellkendalemasmare poortreatmentoutcomesofchildrenonhighlyactiveantiretroviraltherapyprotocolforasystematicreviewandmetaanalysis
AT alenekefyalewaddis poortreatmentoutcomesofchildrenonhighlyactiveantiretroviraltherapyprotocolforasystematicreviewandmetaanalysis